Ethiopia, Norway and the UK have pledged US$240 million to support CEPI’s five‑year plan to strengthen global readiness for epidemic and pandemic threats. Ethiopia will contin ...
HepaRegeniX has announced that the first patient undergoing major liver resection due to liver metastases from colorectal cancer has completed 28 days of treatment with darizmetinib in the second ...
Sanofi and Cheplapharm have announced plans to establish a new strategic partnership that will see Cheplapharm take over 20 mature medicines and three manufacturing sites worldwide. The agreement will ...
AstronauTx has been awarded funding from The Michael J. Fox Foundation for Parkinson’s Research and Parkinson’s UK to advance sleep‑based therapeutic approaches for Parkinson’s disease. The company ...
Roche has welcomed MHRA marketing authorisation for Gazyvaro, indicated for adults with moderate to severe, active, autoantibody-positive systemic lupus erythematosus receiving standard therapy. The ...
TT‑P34 is designed to improve both mitochondrial and lysosomal function, targeting a pathway implicated in multiple ...
EGFR Ex20ins mutations account for around 12% of all EGFR mutations. These patients have historically faced poorer outcomes ...
EpilepsyGTx and Viralgen have announced a partnership to advance production of EPY201, EpilepsyGTx’s lead investigational ...
Axoltis Pharma has reported topline findings from SEALS, its phase 2 study of NX210c in Amyotrophic Lateral Sclerosis. The company said the drug candidate, which aims to restore the blood brain ...
GSK has announced that Japan’s Ministry of Health, Labour and Welfare has approved a prefilled syringe presentation of ...
NICE also endorsed an MRD‑guided approach, allowing daratumumab to be stopped after at least 24 months of maintenance if MRD remains negative for at least 12 months. Scott Purdon, Head of Patient ...
Grünenthal has agreed to acquire Stivarga, an oral treatment for advanced cancers, from Bayer AG for up to €375 million. The company said the deal aligns with its strategy to purchase established ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results